UK Medical Devices Regulation Reform

The Medicines and Healthcare products Regulatory Agency (MHRA) is reforming UK medical devices regulation to align with post-Brexit frameworks and address emerging technologies including AI-enabled devices. The reform covers CE marking recognition, in vitro diagnostics, point-of-care testing, registration requirements, and economic operator responsibilities. This active policy aims to modernise the regulatory pathway while maintaining safety and efficacy standards.